US buys $26M worth of hard-to-get monkeypox treatment

As the U.S. creeps toward 10,000 monkeypox cases, the HHS ordered $26 million worth of Tpoxx IV fluid, a monkeypox treatment that’s difficult for physicians to order, according to an Aug. 9 press release. 

Read the full post on Becker's Hospital Review - Healthcare News